SCHEMBL4543208

SCHEMBL4543208

CCCC(=C=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10803582 0.83
SCHEMBL7054258 0.78
SCHEMBL14343817 0.74 CES1 (0.43)
SCHEMBL27929682 0.72 CES2 (0.33)
SCHEMBL1349449 0.72 CES2 (0.46)
SCHEMBL28069612 0.70 HDAC3 (0.48)
SCHEMBL10431979 0.70
SCHEMBL11904887 0.67
SCHEMBL31303932 0.67 FFAR3 (0.50)
SCHEMBL11341426 0.67 CES1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090306171-A1 INDOLE COMPOUNDS HAVING C4-AMIDE SUBSTITUENTS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS ILYPSA, INC. 2009-12-10 US disclosed
US-20080051447-A1 Treatment Of Hypercholesterolemia, Hypertriglyceridemia And Cardiovascular-Related Conditions Using Phospholipase-A2 Inhibitors ILYPSA, INC. 2008-02-28 US disclosed
US-20080021049-A1 Treatment Of Diet-Related Conditions Using Phospholipase-A2 Inhibitors Comprising Indoles And Related Compounds ILYPSA, INC. 2008-01-24 US disclosed